✦ LIBER ✦

The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemia

✍ Scribed by Carolyn Owen; Jude Fitzgibbon; Peter Paschka

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 116 KB
Volume: 28
Category: Article
ISSN: 0278-0232
DOI: 10.1002/hon.931

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Recurrent genetic aberrations are important predictors of outcome in acute myeloid leukaemia (AML). Numerous novel molecular abnormalities have been identified and investigated in recent years adding to the risk stratification and prognostication of conventional karyotyping. Mutations in the Wilms Tumour 1 (WT1) gene were first described more than a decade ago but their clinical significance has only recently been evaluated. WT1 mutations occur in approximately 10% of adult AML patients at diagnosis and are most frequent in the cytogenetically normal (CN) AML subgroup. These mutations appear to confer a negative prognostic outcome by increasing the risk of relapse and death. Mutation frequency is higher in pediatric patients and also appears to confer a negative impact on relapse and survival. Herein, we discuss the importance of WT1 mutations in AML. Copyright © 2009 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Differential splicing of exon 5 of the W

Differential splicing of exon 5 of the Wilms tumour (WT1) gene

✍ Jane Renshaw; Linda King-Underwood; Kathryn Pritchard-Jones 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

The WT1 gene encodes a developmentally regulated transcription factor whose function is altered by alternative splicing at two sites: the 17 amino acids of exon 5, whose functional effects are ill-defined, and the 3 amino acids (KTS) between exons 9 and 10, which determine sequence-specific DNA bind

THE EXPRESSION PATTERN OF WILMS' TUMOUR

THE EXPRESSION PATTERN OF WILMS' TUMOUR GENE (WT1) PRODUCT IN NORMAL TISSUES AND PAEDIATRIC RENAL TUMOURS

✍ RAMANI, PRAMILA; COWELL, JOHN K. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 791 KB

W T l , the Wilms' tumour suppressor gene located at chromosome llp13, plays an important role in the development of the kidney. It is mutated in 10 per cent of Wilms' tumours (WTs) and their putative precursors called nephrogenic rests (NRs). A sensitive immunohistochemical technique was establishe

Low frequency of mutations in the WT1 co

Low frequency of mutations in the WT1 coding region in Wilms' tumor

✍ Keith W. Brown; Helen P. Wilmore; Joanne E. Watson; Martin G. Mott; P. Jeremy Be 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

## Abstract A series of twenty unselected Wilms′ tumors were analysed for alterations in the __WT1__ tumor suppressor gene. The entire coding region of __WT1__ was amplified by RNA‐PCR, and then screened for mutations by single‐strand conformational polymorphism analysis (SSCP). This method was sho

Analysis of the wilms tumor suppressor g

Analysis of the wilms tumor suppressor gene WT1 in endometrial carcinoma

✍ Raymond Rackley; Graham Casey; Xiao-Ian Zhao; David W. Miller; Bryan R. G. Willi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

## Abstract This study reports on the evaluation of the Wilms tumor suppressor gene __WT1__ in 14 endometrial carcinomas. Despite the fact that several endometrial carcinomas were shown to express __WT1__, we were unable to demonstrate mutations in the __MT1__ zinc finger region, suggesting that __

Overexpression of the Wilms' tumor gene

Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

✍ Yusuke Oji; Shinichiro Miyoshi; Hajime Maeda; Seiji Hayashi; Hiroya Tamaki; Shin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 627 KB

## Abstract Expression of the Wilms' tumor gene __WT1__ in __de novo__ lung cancer was examined using quantitative real‐time RT‐PCR and immunohistochemistry. Overexpression of the __WT1__ gene was detected by RT‐PCR in 54/56 (96%) __de novo__ non‐small cell lung cancers examined and confirmed by de

Mutations of the WT1 gene in childhood n

Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies

✍ Kiyoshi Miyagawa; Yasuhide Hayashi; Toshikatsu Fukuda; Kinuko Mitani; Hisamaru H 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

The Wilms' tumor gene WT1, whose loss of function accounts for the genesis of about 10% of Wilms' tumors, is expressed in hematopoietic stem cells and leukemia. By analogy with the relationship between the kidney stem cell and Wilms' tumor, it is probable that WT1 is mutated in leukemia. WT1 mutatio